This Month’s Focus: Instruments
A practical method for eliminating type I and type II errors when assessing the suitability for continued use of a cascade impactor
Both effective diameter and jet-to-plate criteria are required but the approach is easy.
Back Page: Humble giant of cascade impactors, Virgil A. Marple; August 16, 1939 to December 24, 2017
We count ourselves unbelievably fortunate to have worked with, been mentored by, traveled with and laughed with Virgil Alan Marple over a significant portion of his professional career.
An overview of general chapter development for oral and nasal drug products (OINDPs) at the US Pharmacopeia (USP): Part 1—Normative chapters <5>, <601>, <602>, <603> and <604>
This is the first article of a two-part series that provides an overview of the work currently undertaken by members of the Aerosols Sub-Committee at the USP, focusing on recent updates to the normative and informative chapters within the committee’s remit.
Cross-Industry Organizations: An update on the activities of European COST Action SimInhale
SimInhale is a global network of inhalation experts launched in 2015 and includes 130 members from 27 countries.
A preview of the ISAM 2018 Symposium
ISAM will hold the one-day symposium “Updates and Controversies Related to Inhaled Aerosols” on May 18, 2018 in San Diego, CA, US.
Previewing Drug Device Combination Products
Drug Device Combination Products will take place June 14, 2018 as part of the MedTech Summit, June 11-15 in Brussels, Belgium.
Meeting expectations for FDA nasal spray Q3 structural equivalence
Back Page: Electronic cigarette use among students
Issue focus: Nasal delivery/Nebulizers
Special section: Filling/Packaging
Cross-industry organizations: APSGB and DITL
RDD Asia 2018
January: Reference and Buyer’s Resource
February: Product Development/ Contract Testing
June: Nasal Delivery/Nebulizers
August: Particle Characterization
1155 Northland Drive
St. Paul, MN 55120
Inhalation Article Guidelines
Technical article requirements
The article should be technical and educational, but not promotional. It must be new, not previously published and must be at least 50% different from your previous articles or other articles you are simultaneously developing on the same subject.
All discussions of products or technologies must be in an unbiased, non-promotional, educational manner. If your article discusses products that have been commercialized or are in development, please be aware of the following: Inhalation takes a very limited approach in discussing products, usually listing only product name, delivered drug name and company name, unless a description is provided by the particular company that owns a product, such as in a case study article or product news release. In that way, each company can choose the information it wishes to discuss or disclose about its own products, rather than being discussed by an outside party with no ability to comment prior to publication. However, if an article is a case study, presentation of a novel technology or news article written by the owner company or its representative such as a scientist or consultant, we are happy to consider all information or data they wish to disclose, provided it is presented in a fair-balanced manner.
The article should be 2,500-3,500 words and must include at least five references or items for recommended reading.
We encourage images and/or data tables and have space for three or four of them. We’re flexible about that number so let us know if you need more image space. We also like to publish an additional photo or illustration at the beginning of the article. Images should be sent as separate files that meet the following specifications: high resolution, 300 dpi at a size of 7 x 7 inches and in only JPG, TIF or EPS formats.
Please be aware, due to copyrights, if you use figures or tables from articles that have been previously published in other journals, you must obtain permission from those journals in order to use the images. If you are an author on the published article in question, you may still need permission but there should be no fees from the other journal. If you are not an author and the other journal wants to charge you fees for usage, please contact us before proceeding. We do not want authors incurring costs in order to publish in Inhalation and there may be alternate approaches to citing information that could be used. Also, “open journals” do not charge for image use. If you have any questions or concerns, please contact us.
Editorial board review and production
All of our articles are peer-reviewed and must be accepted by our editorial board or a designated reviewer in order to be published. When you send us the article, it will go to a member of the board and we will coordinate communication between you. Once an article is accepted, we handle production and you will see the final article in layout before it goes to print or is published in the digital edition.